U.S. Capital Wealth Advisors LLC purchased a new stake in shares of Markel Co. (NYSE:MKL – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 25 shares of the insurance provider’s stock, valued at approximately $33,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nomura Asset Management Co. Ltd. lifted its position in Markel by 6.0% during the third quarter. Nomura Asset Management Co. Ltd. now owns 3,175 shares of the insurance provider’s stock valued at $3,442,000 after buying an additional 180 shares in the last quarter. Forsta AP Fonden lifted its position in shares of Markel by 9.2% during the fourth quarter. Forsta AP Fonden now owns 2,600 shares of the insurance provider’s stock worth $3,425,000 after purchasing an additional 220 shares in the last quarter. Mirabella Financial Services LLP acquired a new position in shares of Markel during the third quarter worth $205,000. Somerset Trust Co acquired a new position in shares of Markel during the fourth quarter worth $202,000. Finally, Inspire Investing LLC lifted its position in shares of Markel by 12.6% during the third quarter. Inspire Investing LLC now owns 268 shares of the insurance provider’s stock worth $291,000 after purchasing an additional 30 shares in the last quarter. 75.96% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on MKL. StockNews.com raised shares of Markel from a “hold” rating to a “buy” rating in a research report on Friday, April 28th. Truist Financial lifted their price target on shares of Markel from $1,300.00 to $1,400.00 and gave the stock a “hold” rating in a research note on Friday, February 3rd. One analyst has rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $1,516.67.
Insider Buying and Selling at Markel
Markel Stock Down 2.0 %
Shares of NYSE:MKL opened at $1,346.73 on Wednesday. The company has a current ratio of 0.66, a quick ratio of 0.67 and a debt-to-equity ratio of 0.30. Markel Co. has a 12-month low of $1,064.09 and a 12-month high of $1,458.56. The company has a fifty day simple moving average of $1,299.75 and a 200 day simple moving average of $1,301.14. The firm has a market cap of $17.98 billion, a PE ratio of 65.31 and a beta of 0.78.
Markel (NYSE:MKL – Get Rating) last released its earnings results on Wednesday, February 1st. The insurance provider reported $26.15 earnings per share for the quarter, beating the consensus estimate of $18.47 by $7.68. Markel had a net margin of 2.58% and a return on equity of 8.13%. The firm had revenue of $3.61 billion during the quarter, compared to analyst estimates of $3.45 billion. On average, equities research analysts anticipate that Markel Co. will post 82.37 EPS for the current fiscal year.
Markel Company Profile
Markel Corp. is a financial holding company, which engages in underwriting specialty insurance products for a variety of niche markets. It operates through the Insurance and Reinsurance segments. The Insurance segment includes all direct business and facultative placements written within the company’s underwriting operations.
Featured Stories
- Get a free copy of the StockNews.com research report on Markel (MKL)
- Do Bank Stocks Go Up When Interest Rates Rise?
- How to Invest in Vertical Farming Stocks
- Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding
- Ecolab: Slow And Steady Wins The RaceĀ
- MGM’s Hot Hand Is All In For A Rally, After This Small Break
Want to see what other hedge funds are holding MKL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Markel Co. (NYSE:MKL – Get Rating).
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.